Panagora Asset Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Panagora Asset Management’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-847	Closed	-$2K	–	2530
2016 Q4	$2K	Hold	847	–	–	﹤0.01%	2342
2016 Q3	$5K	Hold	847	–	–	﹤0.01%	2366
2016 Q2	$4K	Sell	847 -25,843	-97%	-$169K	﹤0.01%	2269
2016 Q1	$280K	Sell	26,690 -1,662	-6%	-$33K	﹤0.01%	1541
2015 Q4	$836K	Buy	28,352 +17,537	+162%	+$530K	﹤0.01%	1133
2015 Q3	$342K	Sell	10,815 -378	-3%	-$18.1K	﹤0.01%	1435
2015 Q2	$663K	Buy	11,193 +8,943	+397%	+$631K	﹤0.01%	1249
2015 Q1	$240K	Hold	2,250	–	–	﹤0.01%	1603
2014 Q4	$211K	Sell	2,250 -2,647	-54%	-$252K	﹤0.01%	1604
2014 Q3	$376K	Sell	4,897 -6,046	-55%	-$476K	﹤0.01%	1407
2014 Q2	$983K	Buy	+10,943	New	+$671K	﹤0.01%	1128

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Panagora Asset Management's PTX Position: Q1 2017 in Review

Panagora Asset Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q1 2017, closing a stake of 847 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in PTX in Q2 2014 and held it in 11 quarters. The position peaked at $983K in Q2 2014. 31 funds tracked by Wall St. Rank hold PTX as of Q1 2017.

Panagora Asset Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q1 2017 after selling out during the quarter.
Panagora Asset Management sold 847 Pernix Therapeutics Holdings, Inc. shares in Q1 2017, an estimated $2K.
Panagora Asset Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2014 and held it in 11 quarters.
Panagora Asset Management's Pernix Therapeutics Holdings, Inc. position peaked at $983K in Q2 2014.
31 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q1 2017.

Based on Panagora Asset Management's 13F filing for Q1 2017, filed 15 May 2017.